"S2-5-2) BASIC STRATEGY FOR AVOIDING DRUG INTERACTION DURING STAGE OF DRUG DEVELOPMENT : THE PROPOSALS RELATIVE TO PLANING OF NON-CLINICAL AND CLINICAL STUDIES HOW SHOULD IT BE THE PLANING OF CLINICAL TRIALS (<SYMPOSIUM 2>Strategy how we can learn drug-drug interaction during the development of a new drug)